Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Q4 2024 Earnings Call Transcript March 11, 2025
Zevra Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.67 EPS, expectations were $-0.39.
Operator: Good afternoon, and thank you for joining Zevra’s Therapeutics Fourth Quarter and Full Year 2024 Financial Results and Corporate Update Conference Call. Today’s call is being recorded, and will be available via the Investor Relations section of the company’s website later today. The...
